Clinical Trial Update: A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating tanezumab for endometriosis pain was terminated; results posted later.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Endometriosis | Phase 2 | Status: TERMINATED | Results posted: 2021-04-30